Uzma Sarwar - Concepedia

Author

Uzma Sarwar

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

Lee-Jah Chang, U N Sarwar, U Sarwar, U. N. Sarwar, U. Sarwar, Uzma N Sarwar, Uzma N. Sarwar, Uzma Sarwar, Uzma sarwar

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health Montefiore Medical Center Albert Einstein College of Medicine Emmes (United States)

About

Uzma Sarwar is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, vaccination, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.6K
2	Public Health	3	3	92
3	Epidemiology	3	3	92
4	Social Sciences	1	1	64
5	Cellular Physiology	1	1	64

Uzma Sarwar

Publications

Citations

H-Index

Page 1

	Year	Citations
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine Robert A. Seder, Lee-Jah Chang, Mary E. Enama, Science Pfspz VaccineMalariaImmunologyImmunodominancePlasmodium Falciparum	2013	768
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age Emmanuel B. Walter, Kawsar R. Talaat, Charu Sabharwal, New England Journal of Medicine	2021	611
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination Andrew S. Ishizuka, Kirsten E. Lyke, Adam DeZure, Nature Medicine VaccinationPfspz VaccinationVaccine TargetMalariaImmunology	2016	368
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial Lee-Jah Chang, Kimberly A. Dowd, Floreliz Mendoza, The Lancet VaccinationVaccine SafetyVaccine DevelopmentVaccine TargetVirology	2014	245
Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists Gitte Lund Christensen, Christian D. Kelstrup, Christina Lyngsø, Molecular & Cellular Proteomics	2010	146
Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial Uzma Sarwar, Pamela Costner, Mary E. Enama, The Journal of Infectious Diseases	2014	131
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age Flor M. Muñoz, Lawrence Sher, Charu Sabharwal, New England Journal of Medicine	2023	96
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients Mila B. Ortigoza, Hyunah Yoon, Keith Goldfeld, JAMA Internal Medicine	2021	91
Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus Douglas Herrin, Emily E. Coates, Pamela Costner, Human Vaccines & Immunotherapeutics Hpv Virus-like ParticleImmunologyImmunodominanceInnate ImmunityImmunotherapy	2014	71
Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses Emily E. Coates, Pamela Costner, Martha Nason, Clinical Nuclear Medicine	2017	71

Page 1